Our vision to transform nations is underpinned by love, service, and excellence and is delivered through our highly specialised CREATION.co family
Our expertise revolves around solving your specific problem(s) and, as such, we tailor all of the armoury required to ensure a bespoke offering
CREATION.co represents a heritage of pioneering in healthcare with a history of innovation enabling us to remain at the forefront of insights-led health strategy

CREATION Pinpoint^® is the world’s largest healthcare professional database. It was the world’s first database of confirmed online HCPs. Use our powerful online conversation insights tool to track billions of HCP conversations worldwide in private and public social networks, so you can learn what your customers really think.

Currently, we analyse:

3M+ HCP social media profiles

2B+ conversations

90M+ social media platforms and sites

Our clients are often large global pharmaceutical and healthcare organisations that require insights-led health strategy to solve a problem. In fact, we are proud that most of the top 20 global pharmaceutical companies have worked with us in the last 5 years across various projects and therapies and of those, lots of them continue to work with us on a regular basis.

CREATION Pinpoint works on an algorithm that identifies potential HCPs based on who they are following, who is following them, the write-up in their profile, the language they are using plus a host of other metrics. We then have a team of expert data quality analysts who manually review these HCPs and, with some desk research, confirm if they are/aren’t HCPs. If they are HCPs, they go into our CREATION Pinpoint engine, which means that when we look at conversations happening on public social media about a particular topic, say diabetes, we filter it through CREATION Pinpoint so we end up only seeing conversation HCPs are having around this topic.

In terms of private networks we work with platforms like Sermo which verifies all its members to ensure they are doctors.

We have NDA agreements in place with our clients so projects are highly confidential. However, we have a series of anonymised case studies which can be found here.

With the ability to track a variety of HCP roles including doctors, nurses, pharmacists, and allied health roles to name a few, we can classify insights specific to HCP role type allowing you to differentiate between differing beliefs and tailor communications accordingly.

CREATION.co provides HCP insights in all therapy areas. Having been experts in this field for over 20 years, we have case studies and examples in almost all therapies.

CREATION.co provides HCP insights in any Language in the world. We use local market language specialists in all countries to ensure you are capturing the local nuance.

For knowledge engineering and search, all keywords are entered in their native language and English. This process is repeated for each region in which we operate, and keywords are translated by real people. For content translations (blog posts, tweets, etc) all translations are done by human translators, either from within our team or through third-party translation partners.

CREATION.co provides HCP insights in any Market in the world. Our powerful technology can track HCPs across the globe to provide you with insights from their online conversations in any market you choose. We can also identify which other countries are influencing the markets you are tracking, giving you a true picture of market dynamics.

HCP Insight Trackers

The Top 50 Pharma Tracker

The Product Launch Tracker

The Respiratory Tracker

The US HCP COPD Tracker

Pharma Product Launch Tracker: HCPs celebrated approvals but expressed concerns about access, cost and toxicities

Respiratory Tracker: Trial updates and treatment milestones drive UK HCP respiratory conversations

Top 50 Pharma Tracker: governmental decisions and ASCO 2025 drove HCP conversation about pharma since April

Product Launch Tracker: HCPs celebrate momentous approvals in the rare disease space

Respiratory Tracker: Lung Cancer: The most discussed respiratory condition by HCPs this quarter

You might also be interested in:

Millions of patients may be reporting adverse events. Is pharma listening?

Influence Beyond Borders: The Global Impact of Digital Opinion Leaders on their peers

Unlocking digital influence in pharma: lessons from DOL Finder 2.0

The power of Peer Impact in Digital Opinion Leader (DOL) engagement

Digital Opinion Leaders (DOLs): What they are and why they matter

Pharma Product Launch Tracker: HCPs welcomed monotherapy approvals and signalled growing interest in combination treatments

FAQs